Medical Affairs is booming this quarter...

September has been all about Medical Affairs. So far this quarter, we have successfully closed out several Medical Affairs roles across Europe and the US, and the projects keep on coming! Its been quite a while since Medical Affairs was this busy with exciting new roles for companies building out and launching new products, which is a positive sign that the market is recovering and companies are pushing on with their launch plans.

Through our existing team build partnerships, we are currently resourcing for opportunities spanning Director to SVP level in Country, Regional and Global capacities. All with significant six-figure packages comprising salary, bonus and equity.

Contact me directly for an informal chat or to request details on the following opportunities:-

• Global SVP Medical Affairs. Speciality c10 international launches. Leadership position with multiple reports (MidSize biotech can be based in the UK, Ireland, Germany, Switzerland, Spain or Italy)
• VP, Head of International Medical Affairs. Immunology launch x5 markets. Leadership position with multiple reports and additional hire to be made in new markets (Small/Mid biotech can be based in UK, Ireland, Germany or Switzerland)
• Senior Director International Medical Affairs. Oncology launch EU5. Initially, a standalone role with broad scope to contribute to P3 study design from an MA perspective and future country team builds (Small/Mid Pharma can be based in Germany, France, Italy or Spain)
• UK Medical Director. Innovative allergy launch. Leadership position with x1 direct report and more planned for 2022. (Midsize biotech, this role can be based anywhere in the UK)

Contact Sacha Burgess for an informal chat or to request further details on the following opportunities:-

• CEE Cluster Medical Director. Gene therapy launch (Small biotech can be based anywhere in CEE)
• France and Benelux Cluster Medical Director. Gene therapy launch (Small biotech to be based in France)
• Italy and Iberia Cluster Medical Director. Gene therapy launch (Small biotech to be based in Italy)
• DACH Cluster Medical Director. Gene Therapy launch (Small biotech to be based in Germany)

If you would like to learn more about any of these opportunities or if you would be keen to have a general career catch up call to assess your current position and explore possible next best moves, please do not hesitate to give us a call in